Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapyEugene D. Kwon, Maurice B. Burg, Barbara A. Foster et al.|Proceedings of the National Academy of Sciences|1999Cited by 223